GPR15L (Human) [3752]
GPR15L (Human)
| SMILES | CC(C)CC1NC(=O)C(CCCN=C(N)N)NC(=O)C(C(C)C)NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2c[nH]cn2)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C2CCCN2C(=O)C(CO)NC(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(Cc2c[nH]cn2)NC(=O)C2CSSCC(NC1=O)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c3ccccc13)C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)NC(C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)O)C(C)C)C(C)C)C(C)C)CSSCC(NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C(CO)NC(=O)C(Cc1c[nH]c3ccccc13)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CCCCN)C(C)O)C(=O)N2 |
| InChIKey | MKYBCIBFBPPBKT-UHFFFAOYSA-N |
| Sequence | MRLLVLSSLLCILLLCFSIFSTEGKRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV |
| HELM | PEPTIDE1{K.R.R.P.A.K.A.W.S.G.R.R.T.R.L.C.C.H.R.V.P.S.P.N.S.T.N.L.K.G.H.H.V.R.L.C.K.P.C.K.L.E.P.E.P.R.L.W.V.V.P.G.A.L.P.Q.V}$PEPTIDE1,PEPTIDE1,17:R3-36:R3|PEPTIDE1,PEPTIDE1,16:R3-39:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
GPR15L (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|